Press Statement - Monsanto is pretending to have sold business to a four year old company Tierra Agrotech with a paid up capital of 1 lakh rupees. This needs urgent investigation: Dr Vandana Shiva
New Delhi, January 20, 2018: Raising objections to the proposed merger between Monsanto and Bayer, Dr Vandana Shiva on Saturday submitted her comments and objections to the Competition Commission of India through an email and courier.
Bayer-Monsanto merger if comes through will be the largest cash acquisition. It is pegged at USD 66 Billion. Not only will it have a huge impact on the agri-business of the Europe and United States, but will have consequences globally for farmers and citizens. The proposed merger is perhaps one of the biggest convergences of agribusiness and pharmaceuticals which will adversely affect competition and free trade not only in India but the world.
Speaking in this context Dr. Shiva said:”The Bayer Monsanto merger is not arithmetic issue of economic concentration. It is a political issue. If the mergers go through, it will be spelling the end of peoples’ rights, democracy and constitutional safeguards. In 20 years time Monsanto has illegally captured the cotton seed sector violating biosafety laws and corrupting regulatory agencies.”
She said, “Indian farmers have suffered for Monsanto’s profits and their Bt cotton has left a legacy of poison and death all over the cotton belts of India. Bt cotton which claimed to control pest has failed and now farmers are also dying because of pesticide poisoning.”
“Monsanto illegitimate monopoly is based on the false claim of having a patent on Bt Cotton seeds. India’s patent laws do not allow a patent on seed all that Monsanto has is patent on the method of introducing Bt genes into Cotton. Yet it has used this false claim to a patent, it does not have to lock the Indian seed industry in fraud licensing agreements, collecting illegal royalties from farmers which is the root cause of their distress. Monsanto even has challenged the competition commission of India, when it is investigating Monsanto’s Bt cotton monopoly,” she said.
“An approval of the merger will, therefore, be an approval genocidal monopoly that continues to kill our farmers,” she noted in the letter to the CCI.
To conclude she stated that, “Bayer and Monsanto have based their application for merger on false claims and misleading information. They are therefore liable to pay penalty. At a time when Monsanto is illegally spreading Round-up ready Bt cotton to millions of acres without approval, Bayer Monsanto claim that they are withdrawing from the Round-up Ready market. The merger application falsely claims that Monsanto is no longer in cotton seed business. Monsanto is pretending to have sold business to a four year old company Tierra Agrotech with a paid up capital of 1 lakh rupees. This asset sale needs urgent investigation”.
For any further information please contact I S Singh on 9910589956.
By Dr Vandana Shiva – Mathrubhumi, 12 February 2018
Date:20th Jan 2018
Competition Commission of India,
The Hindustan Times House,
7th Floor, 18-20, Kasturba Gandhi Marg,
Subject : Objections and Comments on proposed Bayer Monsanto Combination as provided under sub-section (3) of section 29 of the Competition Act
Comments submitted by
Name: Dr Vandana Shiva
I submit my comments and objections to the proposed combination between Bayer and Monsanto. The first part is substantive objections to the Bayer application in the context of the of past and potential violations of the Competition Act, 2002. The Second part is my comments on the general impacts of the Bayer Monsanto merger for farmers rights , food security and sovereignty in India and globally.
As the Bayer Application for merger stated, “The Proposed Combination is in the nature of an acquisition (under Section 5(a) of the Competition Act, 2002). As a result of the Proposed Combination, Monsanto will become a wholly owned subsidiary of Bayer.”
Under Section 29(2) of the Competition Act 2002, the Competition Commission, being of the prima facie opinion that the combination of Bayer and Monsanto is likely to have an appreciable adverse effect on competition, has directed the parties seeking a merger and combination to publish details of the combination for bringing it to the knowledge or information of the public and persons affected or likely to be affected by such combination.
The CCI must block the merger because it is an Anti Competitive Agreement violating Section 3 of the Competition Act, It must be rejected under Section 4 because it increases the potential for the abuse of dominant position which the company being acquired, Monsanto, has already engaged in – in the case of Bt cotton. Bayer must also be penalised under Section 44 and 45 of the Competition Act because it has made false statements and is guilty of omitting material relevant to the assessment of the combination. The details of such false statements and omissions have been specifically mentioned in this written objection para-wise. According to Section 44, Bayer is thus liable to a penalty.
25-29 April 2017, Cologne and Bonn Germany
Navdanya, 9 April 2017
27 March 2017
29 November 2016, Bhopal, India
14 – 16 October 2016, The Hague, Netherlands
By Ruchi Shroff, 16 October 2016
By Dr Vandana Shiva – Common Dreams, 12 October 2016
By Dhirendra Kumar – Millenniumpost, 20 September 2016
Navdanya International, 15 July 2016
27 June 2016, Berlin, Germany
The Steering Committee of the Monsanto Tribunal, 8 June 2016